DPP4 and metabolic dysfunction-associated steatotic liver disease: DPP4 activity was demonstrated to be increased in NAFLD patients and correlated with blood transaminases and systemic inflammatory markers [17, 29]; however, in these studies, no data on plasma DPP4 concentration and liver DPP4 levels were available [17, 29].